-

Mária Rašiová1, Martin Koščo1, Veronika Pavlíková1

  • 1Department of Angiology, East Slovak Institute of Cardiovascular Diseases, Faculty of Medicine, Šafárik University, Košice, Slovakia.

Vascular
|June 14, 2024
PubMed
概括

在内血管腹腔大动脉修复 (EVAR) 后降低死亡率至关重要. 重复干预和ACE抑制剂/ARBs可能会降低死亡率,而更大的动脉瘤直径和冠状动脉疾病会增加风险.